Trade on Pluang

One platform for all markets

Download

Investment

Features

Fees Safety

Academy

Pluang+

Home/News Feed/Viatris upgraded to Strong Buy on strong pipeline and growth prospects.

VTRS

$17.37

$0.00 0.00%

Viatris upgraded to Strong Buy on strong pipeline and growth prospects.

Name: Pluang-Trading US Stock Crypto
Availability: InStock
Rating: 4.75 (117517 reviews)
Author: pluang

Analyst Insights

12 May 2026

Seeking Alpha

View Source

Bullish

Viatris has been upgraded to a Strong Buy rating due to its robust pipeline catalysts and credible long-term growth plan. The company aims for a five-year sales CAGR midpoint of 3.5%, which surpasses market consensus, supported by $450–550 million in annual new product contributions and growth from branded assets. Key products like Selatogrel and Cenerimod, along with upcoming launches such as meloxicam, are expected to drive growth acceleration and margin expansion. Management forecasts $11 billion in cash generation through 2030 to support disciplined capital allocation, selective mergers and acquisitions, and a strategic shift toward higher-value generics.

More News (VTRS)

Presbyopia market to grow at 4.9% CAGR by 2036, driven by aging population and new treatments.

The global presbyopia market is projected to grow at a compound annual growth rate (CAGR) of 4.9% from 2026 to 2036, fueled by the increasing aging population and rising prevalence of near vision impairment. Market expansion is supported by greater a...

Market News

Bullish

2 days ago